ISSN: 1792-1074
Journal Home
Journal Guideline
Oncology Letters Q3 Unclaimed
Oncology Letters is a journal indexed in SJR in Oncology and Cancer Research with an H index of 81. It has an SJR impact factor of 0,644 and it has a best quartile of Q3. It has an SJR impact factor of 0,644.
Oncology Letters focuses its scope in these topics and keywords: cancer, cell, expression, factor, breast, patients, genes, ovarian, case, gene, ...
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,644
SJR Impact factor81
H Index510
Total Docs (Last Year)2474
Total Docs (3 years)21927
Total Refs6235
Total Cites (3 years)2473
Citable Docs (3 years)2.41
Cites/Doc (2 years)42.99
Ref/DocOther journals with similar parameters
Cancer Management and Research Q3
Journal of Breast Cancer Q3
Breast Cancer: Basic and Clinical Research Q3
Clinical Medicine Insights: Oncology Q3
Journal of Gastrointestinal Oncology Q3
Compare this journals
Aims and Scope
Best articles by citations
Downregulated long non-coding RNA DREH promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinoma
View moreExpression of Livin and PlGF in human osteosarcoma is associated with tumor progression and clinical outcome
View moreRole of microRNA-4458 in patients with non-small-cell lung cancer
View moreDifferential expression of the Na+/I- symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues
View moreRecurrent female adnexal tumor of probable Wolffian origin treated with debulking surgery, imatinib and paclitaxel/carboplatin combination chemotherapy: A case report
View moreBrain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study
View moreIntracellular IL-4 and IFN- gamma expression in iNKT cells from patients with chronic lymphocytic leukemia
View moreLINK-A lncRNA is upregulated in osteosarcoma and regulates migration, invasion and stemness of osteosarcoma cells
View moreExpression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy
View moreNEDD9 promotes invasion and migration of colorectal cancer cell line HCT116 via JNK/EMT
View moreSequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer
View moreBone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment
View moreMetastatic B-cell lymphoma masquerading as infectious retinitis and vasculitis
View moreBiliary papillomatosis with malignant transformation: A case report and review of the literature
View moreCytoskeleton-associated membrane protein'4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma
View moreTiming of changing therapy from gemcitabine and cisplatin chemotherapy based on real-world data of advanced urothelial carcinoma
View moreEphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel
View moreLaccase purified from Cerrena unicolor exerts antitumor activity against leukemic cells
View moreJuglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3beta/Snail signaling pathway
View moreGenistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling
View moreUltra-early microsurgical treatment within 24 h of SAH improves prognosis of poor-grade aneurysm combined with intracerebral hematoma
View moreSNHG20 serves as a predictor for prognosis and promotes cell growth in oral squamous cell carcinoma
View moreSNHG20/miR-140-5p/NDRG3 axis contributes to 5-fluorouracil resistance in gastric cancer
View moreOutcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy
View more
Comments